Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 6:37 PM View:  | Omniab, Inc. (OABI) | 08-Apr-24 | Option Sale | 6,954 | $5.27 | $36,647.60 | (2%) 299.57K to 292.62K | |
| 09-Apr-24 6:37 PM View: | Omniab, Inc. (OABI) | 07-Apr-24 | Option Exercise | 13,541 | -- | -- | 5% 286.03K to 299.57K | |
| 20-Feb-24 6:22 PM View: | Omniab, Inc. (OABI) | 15-Feb-24 | Payment of Exercise | 7,609 | $5.54 | $42,153.90 | (3%) 293.64K to 286.03K | |
| 20-Feb-24 6:22 PM View: | Omniab, Inc. (OABI) | 15-Feb-24 | Option Exercise | 21,322 | -- | -- | 8% 272.32K to 293.64K | |
| 03-Jan-24 5:42 PM View: | Omniab, Inc. (OABI) | 02-Jan-24 | Payment of Exercise | 7,195 | $6.25 | $44,968.80 | (3%) 279.51K to 272.32K | |
| 03-Jan-24 5:42 PM View: | Omniab, Inc. (OABI) | 02-Jan-24 | Option Exercise | 17,556 | -- | -- | 7% 261.96K to 279.51K | |
| 11-Dec-23 7:21 PM View: | Omniab, Inc. (OABI) | 07-Dec-23 | Payment of Exercise | 5,403 | $4.85 | $26,204.50 | (2%) 267.36K to 261.96K | |
| 11-Dec-23 7:21 PM View: | Omniab, Inc. (OABI) | 07-Dec-23 | Option Exercise | 15,622 | -- | -- | 6% 251.74K to 267.36K | |
| 11-Apr-23 7:11 PM View: | Omniab, Inc. (OABI) | 07-Apr-23 | Grant | 40,625 | -- | -- | 11% 373.94K to 414.56K | |
| 17-Feb-23 7:50 PM View: | Omniab, Inc. (OABI) | 15-Feb-23 | Payment of Exercise | 9,543 | $3.80 | $36,263.40 | (2%) 383.48K to 373.94K | |
| 05-Jan-23 5:06 PM View: | Omniab, Inc. (OABI) | 03-Jan-23 | Grant | 46,864 | -- | -- | 14% 336.62K to 383.48K | |
| 30-Dec-22 5:00 PM View: | Omniab, Inc. (OABI) | 28-Dec-22 | Payment of Exercise | 6,518 | $3.66 | $23,855.90 | (2%) 343.14K to 336.62K | |
| 05-Dec-22 9:41 PM View: | Omniab, Inc. (OABI) | 01-Dec-22 | Payment of Exercise | 10,580 | $3.35 | $35,443.00 | (3%) 353.72K to 343.14K | |
| 03-Nov-22 9:16 PM View: | Omniab, Inc. (OABI) | 01-Nov-22 | Grant | 353,716 | -- | -- | 100% 0 to 353.72K | |
| 03-Nov-22 9:08 PM View: | Omniab, Inc. (NONE) | 01-Nov-22 | Grant | 15,409 | -- | -- | 41% 37.18K to 52.59K | |
| 03-Nov-22 9:08 PM View: | Omniab, Inc. (NONE) | 01-Nov-22 | Disposition | 52,587 | -- | -- | (100%) 52.59K to 0 | |
| 03-Nov-22 9:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Nov-22 | Disposition | 11,944 | -- | -- | (33%) 35.77K to 23.82K | |
| 14-Jun-22 5:55 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-22 | Grant | 5,375 | -- | -- | 18% 30.39K to 35.77K | |
| 16-Feb-22 8:24 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-22 | Payment of Exercise | 1,578 | $123.68 | $195,167.00 | (5%) 31.97K to 30.39K | |
| 28-Jan-22 8:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 26-Jan-22 | Grant | 6,237 | -- | -- | 22% 27.89K to 34.13K | |
| 28-Jan-22 8:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 26-Jan-22 | Payment of Exercise | 2,156 | $113.68 | $245,094.00 | (6%) 34.13K to 31.97K | |
| 18-Feb-21 6:28 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-21 | Payment of Exercise | 1,015 | $172.46 | $175,047.00 | (4%) 28.91K to 27.89K | 25% |
| 05-Feb-21 5:03 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Feb-21 | Market Sale | 18,097 | $178.50 | $3,230,380.00 | (39%) 47.0K to 28.91K | 27% |
| 05-Feb-21 5:03 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 03-Feb-21 | Grant | 3,491 | -- | -- | 8% 43.51K to 47.0K | |
| 27-Jan-21 7:02 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 25-Jan-21 | Grant | 3,736 | -- | -- | 9% 41.12K to 44.85K | |
| 27-Jan-21 7:02 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 25-Jan-21 | Payment of Exercise | 1,339 | $156.04 | $208,943.00 | (3%) 44.85K to 43.51K | 17% |
| 01-Jul-20 8:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jun-20 | Acquisition (other) | 238 | $89.03 | $21,188.90 | < 1% 40.88K to 41.12K | |
| 05-Jun-20 4:07 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Jun-20 | Market Sale | 11,146 | $118.59 | $1,321,780.00 | (21%) 52.02K to 40.88K | (10%) |
| 18-Feb-20 5:07 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-20 | Payment of Exercise | 881 | $97.23 | $85,659.60 | (2%) 52.9K to 52.02K | (34%) |
| 18-Feb-20 5:07 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 13-Feb-20 | Grant | 3,835 | -- | -- | 8% 49.07K to 52.9K | |
| 26-Dec-19 2:01 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-Dec-19 | Grant | 3,028 | -- | -- | 6% 47.17K to 50.2K | |
| 26-Dec-19 2:01 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-Dec-19 | Payment of Exercise | 1,131 | $105.87 | $119,739.00 | (2%) 50.2K to 49.07K | (23%) |
| 06-Aug-19 5:17 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Aug-19 | Option Exercise | 1,093 | $67.72 | $74,012.90 | 2% 46.08K to 47.17K | |
| 02-Jul-19 9:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Jun-19 | Acquisition (other) | 182 | $97.03 | $17,659.00 | < 1% 45.9K to 46.08K | |
| 13-Feb-19 4:34 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-Feb-19 | Grant | 3,202 | -- | -- | 7% 42.7K to 45.9K | |
| 25-Jan-19 4:32 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Jan-19 | Grant | 2,782 | -- | -- | 7% 39.91K to 42.7K | |
| 14-Jan-19 9:17 AM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jan-19 | Option Exercise | 2,850 | $65.62 | $187,029.00 | 8% 37.06K to 39.91K | |
| 17-Dec-18 7:58 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Dec-18 | Option Exercise | 3,400 | $21.92 | $74,528.00 | 10% 33.66K to 37.06K | |
| 25-Oct-18 5:44 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 24-Oct-18 | Option Exercise | 3,900 | $16.79 | $65,462.40 | 13% 29.76K to 33.66K | |
| 12-Oct-18 6:52 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-Oct-18 | Option Exercise | 2,000 | $14.47 | $28,940.00 | 7% 27.76K to 29.76K | |
| 18-Sep-18 6:16 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Sep-18 | Option Exercise | 2,813 | $100.38 | $282,369.00 | 10% 27.76K to 30.58K | |
| 18-Sep-18 6:16 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Sep-18 | Market Option Sale (Planned) | 2,813 | $250.69 | $705,181.00 | (9%) 30.58K to 27.76K | 48% |
| 05-Sep-18 8:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Sep-18 | Option Exercise | 19,417 | $69.98 | $1,358,800.00 | 70% 27.76K to 47.18K | |
| 05-Sep-18 8:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Sep-18 | Market Option Sale (Planned) | 19,417 | $254.99 | $4,951,060.00 | (41%) 47.18K to 27.76K | 49% |
| 03-Jul-18 3:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-Jun-18 | Acquisition (other) | 180 | $117.84 | $21,210.40 | < 1% 27.58K to 27.76K | |
| 06-Mar-18 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Mar-18 | Grant | 1,136 | -- | -- | 4% 26.84K to 27.98K | |
| 06-Mar-18 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Mar-18 | Payment of Exercise | 392 | $165.87 | $65,021.00 | (1%) 27.98K to 27.58K | 22% |
| 06-Mar-18 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 02-Mar-18 | Grant | 1,780 | -- | -- | 7% 25.06K to 26.84K | |
| 16-Feb-18 5:40 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-18 | Payment of Exercise | 1,036 | $157.18 | $162,838.00 | (4%) 26.09K to 25.06K | 17% |
| 29-Dec-17 9:16 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Dec-17 | Grant | 2,847 | -- | -- | 12% 24.42K to 27.27K |